Ultimately, the study of PPARγ is expected to provide a new therapeutic approach for the treatment of ischemic cerebrovascular diseases, and it is important for the prevention of neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, and Huntington's disease. Here, PPARG is linked to juvenile Huntington disease.